SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-030651
Filing Date
2022-03-04
Accepted
2022-03-04 16:56:43
Documents
15
Period of Report
2022-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm228418d1_8k.htm   iXBRL 8-K 27165
2 EXHIBIT 1.1 tm228418d1_ex1-1.htm EX-1.1 17746
3 EXHIBIT 5.1 tm228418d1_ex5-1.htm EX-5.1 14558
7 GRAPHIC tm228418d1_ex5-1img01.jpg GRAPHIC 9660
  Complete submission text file 0001104659-22-030651.txt   255523

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA edsa-20220304.xsd EX-101.SCH 3045
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20220304_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20220304_pre.xml EX-101.PRE 22603
9 EXTRACTED XBRL INSTANCE DOCUMENT tm228418d1_8k_htm.xml XML 3572
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 22714938
SIC: 2834 Pharmaceutical Preparations